Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
Jürgen Sonnemann, Christian Marx, Jonathan Becker, et al.
British Journal of Cancer (2013) Vol. 110, Iss. 3, pp. 656-667
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li, Edward Seto
Cold Spring Harbor Perspectives in Medicine (2016) Vol. 6, Iss. 10, pp. a026831-a026831
Open Access | Times Cited: 1043
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Robert Jenke, Nina Reßing, Finn K. Hansen, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 634-634
Open Access | Times Cited: 137
HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer
Nataša Stojanović, Zonera Hassan, Matthias Wirth, et al.
Oncogene (2016) Vol. 36, Iss. 13, pp. 1804-1815
Closed Access | Times Cited: 99
Histone Modifications and their Role in Colorectal Cancer (Review)
Jingchun Qin, Bin Wen, Yuqi Liang, et al.
Pathology & Oncology Research (2019) Vol. 26, Iss. 4, pp. 2023-2033
Open Access | Times Cited: 83
Clinical advances in targeting epigenetics for cancer therapy
Shengrui Feng, Daniel D. De Carvalho
FEBS Journal (2021) Vol. 289, Iss. 5, pp. 1214-1239
Open Access | Times Cited: 71
Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis
Tobias Wagner, P. W. J. L. Brand, Thorsten Heinzel, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2014) Vol. 1846, Iss. 2, pp. 524-538
Closed Access | Times Cited: 82
HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis
Hyun-Wook Ryu, Dong‐Hee Shin, Dong Hoon Lee, et al.
Cancer Letters (2017) Vol. 391, pp. 162-171
Closed Access | Times Cited: 74
p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death
Maria Mrakovcic, Johannes Kleinheinz, Leopold F. Fröhlich
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2415-2415
Open Access | Times Cited: 73
Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells
Umamaheswari Natarajan, Thiagarajan Venkatesan, Vijayaraghavan Radhakrishnan, et al.
Cells (2018) Vol. 8, Iss. 1, pp. 8-8
Open Access | Times Cited: 71
Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization
Carina Fischer, Katharina Leithner, Christoph Wohlkoenig, et al.
Molecular Cancer (2015) Vol. 14, Iss. 1, pp. 4-4
Open Access | Times Cited: 69
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
Dimitris Karagiannis, Θεόδωρος Ράμπιας
Cancers (2021) Vol. 13, Iss. 14, pp. 3575-3575
Open Access | Times Cited: 54
Preventing Colorectal Cancer through Prebiotics
Manijeh Mahdavi, Isabelle Laforest‐Lapointe, Éric Massé
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1325-1325
Open Access | Times Cited: 47
Characterization of Histone Deacetylase Mechanisms in Cancer Development
Rihan Hai, Liuer He, Guang Shu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding
Eun Young Park, Youngwoo Woo, Seong‐Jin Kim, et al.
International Journal of Biological Sciences (2016) Vol. 12, Iss. 12, pp. 1555-1567
Open Access | Times Cited: 56
Nutraceuticals in colorectal cancer: A mechanistic approach
Marco Rossi, Seyed Sina Mirbagheri, Ali Keshavarzian, et al.
European Journal of Pharmacology (2018) Vol. 833, pp. 396-402
Open Access | Times Cited: 56
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
Nicole Kiweler, Desirée Wünsch, Matthias Wirth, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 2, pp. 343-356
Open Access | Times Cited: 45
Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors
Kunal Nepali, Ting-Yu Chang, Mei-Jung Lai, et al.
European Journal of Medicinal Chemistry (2020) Vol. 196, pp. 112291-112291
Closed Access | Times Cited: 42
p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act
Yuanfang Guo, Yufeng Tang, Guangping Lu, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2259-2259
Open Access | Times Cited: 14
Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium
Shaowei Chen, Xiao Yao, Yuwen Li, et al.
Development (2015) Vol. 142, Iss. 6, pp. 1180-1192
Open Access | Times Cited: 46
Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells
Claudia Schäfer, Anja Göder, Mandy Beyer, et al.
Cellular Signalling (2016) Vol. 29, pp. 218-225
Closed Access | Times Cited: 46
Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines
Eva Bernhart, Nicole Stuendl, Heike Kaltenegger, et al.
Oncotarget (2017) Vol. 8, Iss. 44, pp. 77254-77267
Open Access | Times Cited: 44
Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression
Pedro A. Lazo
Cellular Signalling (2017) Vol. 33, pp. 49-58
Open Access | Times Cited: 42
Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat
Tamara Zenz, Robert Jenke, Denys Oliinyk, et al.
Neoplasia (2025) Vol. 60, pp. 101121-101121
Closed Access
DNA damage response regulator ATR licenses PINK1-mediated mitophagy
Christian Marx, Xiaobing Qing, Yamin Gong, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 5
Open Access
Mechanisms of HDACs in cancer development
Ying Zhang, Haotian Wang, Zhumei Zhan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top